Back-to-School 2026: Navigating Vaccine Uncertainty Amidst Rising Measles Cases

Key points

• President Trump signed an executive order in August 2026 calling for 'more vaccine flexibility' and fewer childhood vaccinations, though he stated parents can still choose to vaccinate and insurance will cover it.
• CDC data shows kindergarten vaccination coverage fell by 0.1% in the 2025-2026 school year, continuing a downward trend since the pandemic, with MMR, DTaP, and polio coverage dropping in over half of U.S. states.
• The U.S. is experiencing its worst measles resurgence in over 30 years, with experts warning that a single unvaccinated child in a classroom can spark outbreaks affecting dozens of families.
• Updated flu and COVID-19 vaccines are available for the season, with insurance coverage confirmed, despite stalled CDC Advisory Committee on Immunization Practices (ACIP) meetings.
• Whooping cough (pertussis) cases reached their highest level since 2012 in 2025, driven by declining vaccination rates and waning immunity, posing severe risks to infants too young to be fully vaccinated.

Background

This situation follows a series of developments in 2026, including the FDA's approval of Moderna's mRNA-based flu vaccine (mFlusiva) for adults 50 and older, which aims to improve strain matching but faces uncertainty regarding insurance coverage and widespread availability. Earlier in the year, a federal judge blocked some attempts to slash the childhood vaccine schedule, setting the stage for the current policy conflict. The ongoing decline in vaccination rates has been a persistent concern since the pandemic, with 2025 marking a significant increase in whooping cough cases.

How outlets are covering it

USA Today emphasizes the critical importance of routine vaccinations for student safety, highlighting the risks of measles and whooping cough outbreaks due to declining coverage. The Gazette, focusing on Iowa, notes that while state immunization requirements remain unchanged, there is a troubling rise in the use of religious exemptions as philosophical ones, with 4.3% of students having a religious exemption in schools. RFD-TV, through Dr. Jeffrey Gold, stresses that vaccination decisions should be based on scientific evidence and conversations with healthcare professionals, noting that the number of unvaccinated kindergarteners has exceeded 4%. King County Public Health urges families to make back-to-school vaccination appointments now, emphasizing that vaccinations are required for school and child care, and that where kids thrive, so do germs. The perspectives differ in their focus: USA Today and King County highlight the public health risks and the need for action, while The Gazette and RFD-TV focus on the confusion and the role of healthcare providers in guiding families through the noise.

Why it matters

The declining vaccination rates and policy uncertainty directly impact the health and safety of millions of children as they return to school. The resurgence of measles and whooping cough, diseases that are highly contagious and can be severe, underscores the importance of maintaining high vaccination coverage. The confusion caused by federal policy changes and stalled advisory meetings can lead to vaccine hesitancy, potentially resulting in outbreaks that could have been prevented. Ensuring that families have access to accurate, evidence-based information is crucial for protecting public health and maintaining the safety of school environments.

What to watch

Families are encouraged to consult their healthcare providers for evidence-based recommendations on vaccinations, including flu and COVID-19 shots, which are available and covered by insurance. Health experts are urging parents to prioritize routine vaccinations to protect their children and the broader community. The CDC and other medical societies are committed to providing evidence-based recommendations, but the stalled ACIP meetings may delay updates to guidance. Monitoring the impact of the executive order and the trend in vaccination coverage will be critical in the coming months, as will the availability and uptake of the new mRNA flu vaccine for adults 50 and older.